Annotation Detail for ARHGAP23

Basic Information
Top
Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C472791 |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid |
3-(4'-hydroxy-3'-adamantylbiphenyl-4-yl)acrylic acid results in increased expression of ARHGAP23 mRNA | increases expression | 16788091
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ARHGAP23 mRNA | decreases expression | 19150397
|
D006830 |
Hydralazine |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP23 mRNA | affects cotreatment|increases expression | 17183730
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ARHGAP23 mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of ARHGAP23 mRNA | increases expression | 18301758
|
D014635 |
Valproic Acid |
[Hydralazine co-treated with Valproic Acid] results in increased expression of ARHGAP23 mRNA | affects cotreatment|increases expression | 17183730
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
4.02 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.30 | 19490988 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.52 | 18653653 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
4.02 | 16434500 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.85 | 17688650 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.86 | 17497229 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.98 | 16609825 18558336 18775368 19460635 18177632 18985861 17688650 15238991 17157402 19232924 18316065 17507914 18940202 20603192 18396377 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.23 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
3.52 | 19483382 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.61 | 8888407 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.96 | 20889678 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.81 | 20734317 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
3.08 | 19176532 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
1.90 | 17688650 8888407 16575769 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.56 | 18249437 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
2.25 | 19641884 1733752 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.45 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
2.85 | 12083418 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.64 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.53 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.09 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.91 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.78 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.60 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
8.99 | 19236843 20131406 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.99 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.50 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.57 | 8888407 18558336 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.73 | 20558911 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
3.48 | 16221962 18467677 19772884 19176532 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.41 | 17688650 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.53 | 20558911 |
MESH:D046110 |
Hypertension, Pregnancy-Induced |
|
Hydralazine |
5.11 | 16612254 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.85 | 16306350 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
2.19 | 16294345 17596541 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
1.35 | 15474484 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
1.92 | 15890375 16377806 20007298 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.87 | 17228818 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.44 | 18765137 18803445 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.99 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.40 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
3.33 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.26 | 19151258 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.22 | 16411023 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
2.09 | 17405874 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
3.34 | 8888407 16359493 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.88 | 20558911 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.37 | 20603192 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
5.15 | 12752131 11422049 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.53 | 19058328 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.58 | 19155313 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.10 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.96 | 16876388 15475178 3137016 17978042 11044598 11738929 14763951 1511512 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
4.06 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
5.15 | 12833885 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.85 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
5.06 | 3119515 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
5.13 | 8888407 |